ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
Dow Jones
39.150,33
0,04%
Euro vs US Dollar
1,06925
0,00%
Bitcoin
64.111,69
-0,21%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Horizon Therapeutics Public Limited Company (HZNP)

  7. Horizon Therapeutics Public Limited Company (HZNP) News

HZNP

Horizon Therapeutics Pub... (HZNP)

Horizon Therapeutics Public Limited Company
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HZNP
DatumZeitQuelleÜberschriftSymbolFirma
16/10/202322h44Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:HZNPHorizon Therapeutics Public Limited Company
09/10/202313h33IH Market NewsMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and moreNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
07/10/202300h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202323h59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202323h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202323h51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h24Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h22Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h13Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h11Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
06/10/202314h30Business WireRule 17(e) Announcement - Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/10/202313h40Business WireRule 17(d) Announcement – Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
05/10/202313h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/10/202317h15Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
03/10/202317h06Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202317h39Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202317h24Business WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
02/10/202314h00Business WireHorizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023NASDAQ:HZNPHorizon Therapeutics Public Limited Company
 Showing the most relevant articles for your search:NASDAQ:HZNP

Kürzlich von Ihnen besucht

EU
SGEG1
Euronext G Engie 020522 ...
BOV
VIVR12
VIVER
LSE
GLB
Glanbia
BOV
EVEN3F
EVEN ON
LSE
0SAN
Sandoz
BIT
RAT
RATTI
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten